166 related articles for article (PubMed ID: 35311452)
21. The WD40 domain of ATG16L1 is required for its non-canonical role in lipidation of LC3 at single membranes.
Fletcher K; Ulferts R; Jacquin E; Veith T; Gammoh N; Arasteh JM; Mayer U; Carding SR; Wileman T; Beale R; Florey O
EMBO J; 2018 Feb; 37(4):. PubMed ID: 29317426
[TBL] [Abstract][Full Text] [Related]
22. ATG16L1 and NOD2 interact in an autophagy-dependent antibacterial pathway implicated in Crohn's disease pathogenesis.
Homer CR; Richmond AL; Rebert NA; Achkar JP; McDonald C
Gastroenterology; 2010 Nov; 139(5):1630-41, 1641.e1-2. PubMed ID: 20637199
[TBL] [Abstract][Full Text] [Related]
23. A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1.
Hampe J; Franke A; Rosenstiel P; Till A; Teuber M; Huse K; Albrecht M; Mayr G; De La Vega FM; Briggs J; Günther S; Prescott NJ; Onnie CM; Häsler R; Sipos B; Fölsch UR; Lengauer T; Platzer M; Mathew CG; Krawczak M; Schreiber S
Nat Genet; 2007 Feb; 39(2):207-11. PubMed ID: 17200669
[TBL] [Abstract][Full Text] [Related]
24. TMEM59 defines a novel ATG16L1-binding motif that promotes local activation of LC3.
Boada-Romero E; Letek M; Fleischer A; Pallauf K; Ramón-Barros C; Pimentel-Muiños FX
EMBO J; 2013 Feb; 32(4):566-82. PubMed ID: 23376921
[TBL] [Abstract][Full Text] [Related]
25. The Crohn's disease polymorphism,
Lavoie S; Conway KL; Lassen KG; Jijon HB; Pan H; Chun E; Michaud M; Lang JK; Gallini Comeau CA; Dreyfuss JM; Glickman JN; Vlamakis H; Ananthakrishnan A; Kostic A; Garrett WS; Xavier RJ
Elife; 2019 Jan; 8():. PubMed ID: 30666959
[TBL] [Abstract][Full Text] [Related]
26. An alteration in ATG16L1 stability in Crohn disease.
Lassen KG; Xavier RJ
Autophagy; 2014 Oct; 10(10):1858-60. PubMed ID: 25136803
[TBL] [Abstract][Full Text] [Related]
27. ATG16L1 rs2241880/T300A increases susceptibility to perianal Crohn's disease: An updated meta-analysis on inflammatory bowel disease risk and clinical outcomes.
Simovic I; Hilmi I; Ng RT; Chew KS; Wong SY; Lee WS; Riordan S; Castaño-Rodríguez N
United European Gastroenterol J; 2024 Feb; 12(1):103-121. PubMed ID: 37837511
[TBL] [Abstract][Full Text] [Related]
28. The
Hamaoui D; Cossé MM; Mohan J; Lystad AH; Wollert T; Subtil A
Proc Natl Acad Sci U S A; 2020 Oct; 117(43):26784-26794. PubMed ID: 33055216
[TBL] [Abstract][Full Text] [Related]
29. IBD-Associated Atg16L1T300A Polymorphism Regulates Commensal Microbiota of the Intestine.
Liu H; Gao P; Jia B; Lu N; Zhu B; Zhang F
Front Immunol; 2021; 12():772189. PubMed ID: 35154071
[TBL] [Abstract][Full Text] [Related]
30. ATG16L1 T300A polymorphism and Crohn's disease susceptibility: evidence from 13,022 cases and 17,532 controls.
Zhang HF; Qiu LX; Chen Y; Zhu WL; Mao C; Zhu LG; Zheng MH; Wang Y; Lei L; Shi J
Hum Genet; 2009 Jun; 125(5-6):627-31. PubMed ID: 19337756
[TBL] [Abstract][Full Text] [Related]
31. Crohn's disease-associated ATG16L1 polymorphism modulates pro-inflammatory cytokine responses selectively upon activation of NOD2.
Plantinga TS; Crisan TO; Oosting M; van de Veerdonk FL; de Jong DJ; Philpott DJ; van der Meer JW; Girardin SE; Joosten LA; Netea MG
Gut; 2011 Sep; 60(9):1229-35. PubMed ID: 21406388
[TBL] [Abstract][Full Text] [Related]
32. Crohn's disease-associated ATG16L1 T300A genotype is associated with improved survival in gastric cancer.
Ma C; Storer CE; Chandran U; LaFramboise WA; Petrosko P; Frank M; Hartman DJ; Pantanowitz L; Haritunians T; Head RD; Liu TC
EBioMedicine; 2021 May; 67():103347. PubMed ID: 33906066
[TBL] [Abstract][Full Text] [Related]
33. The complex interplay of NOD-like receptors and the autophagy machinery in the pathophysiology of Crohn disease.
Billmann-Born S; Lipinski S; Böck J; Till A; Rosenstiel P; Schreiber S
Eur J Cell Biol; 2011; 90(6-7):593-602. PubMed ID: 21146253
[TBL] [Abstract][Full Text] [Related]
34. A nonsynonymous SNP in ATG16L1 predisposes to ileal Crohn's disease and is independent of CARD15 and IBD5.
Prescott NJ; Fisher SA; Franke A; Hampe J; Onnie CM; Soars D; Bagnall R; Mirza MM; Sanderson J; Forbes A; Mansfield JC; Lewis CM; Schreiber S; Mathew CG
Gastroenterology; 2007 May; 132(5):1665-71. PubMed ID: 17484864
[TBL] [Abstract][Full Text] [Related]
35. IL23R R381Q and ATG16L1 T300A are strongly associated with Crohn's disease in a study of New Zealand Caucasians with inflammatory bowel disease.
Roberts RL; Gearry RB; Hollis-Moffatt JE; Miller AL; Reid J; Abkevich V; Timms KM; Gutin A; Lanchbury JS; Merriman TR; Barclay ML; Kennedy MA
Am J Gastroenterol; 2007 Dec; 102(12):2754-61. PubMed ID: 17894849
[TBL] [Abstract][Full Text] [Related]
36. Impaired autophagy of an intracellular pathogen induced by a Crohn's disease associated ATG16L1 variant.
Kuballa P; Huett A; Rioux JD; Daly MJ; Xavier RJ
PLoS One; 2008; 3(10):e3391. PubMed ID: 18852889
[TBL] [Abstract][Full Text] [Related]
37. MIR106B and MIR93 prevent removal of bacteria from epithelial cells by disrupting ATG16L1-mediated autophagy.
Lu C; Chen J; Xu HG; Zhou X; He Q; Li YL; Jiang G; Shan Y; Xue B; Zhao RX; Wang Y; Werle KD; Cui R; Liang J; Xu ZX
Gastroenterology; 2014 Jan; 146(1):188-99. PubMed ID: 24036151
[TBL] [Abstract][Full Text] [Related]
38. The ATG16L1 gene variant rs2241880 (p.T300A) is associated with susceptibility to HCC in patients with cirrhosis.
Reuken PA; Lutz P; Casper M; Al-Herwi E; Stengel S; Spengler U; Stallmach A; Lammert F; Nischalke HD; Bruns T
Liver Int; 2019 Dec; 39(12):2360-2367. PubMed ID: 31484215
[TBL] [Abstract][Full Text] [Related]
39. Mir223 restrains autophagy and promotes CNS inflammation by targeting ATG16L1.
Li Y; Zhou D; Ren Y; Zhang Z; Guo X; Ma M; Xue Z; Lv J; Liu H; Xi Q; Jia L; Zhang L; Liu Y; Zhang Q; Yan J; Da Y; Gao F; Yue J; Yao Z; Zhang R
Autophagy; 2019 Mar; 15(3):478-492. PubMed ID: 30208760
[TBL] [Abstract][Full Text] [Related]
40. ATG16L1 functions in cell homeostasis beyond autophagy.
Hamaoui D; Subtil A
FEBS J; 2022 Apr; 289(7):1779-1800. PubMed ID: 33752267
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
